← back to search

Iker Falces‐Romero

Hospital Universitario La Paz · ES
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include COVID-19 Clinical Research Studies, Antifungal resistance and susceptibility, Fungal Infections and Studies, and SARS-CoV-2 and COVID-19 Research.
h-index
25
citations
2,182
works
133
NIH funding
primary concept
Medicine
email

Recent publications

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
EClinicalMedicine 2024cited by 30position: middledoi
Epidemiological and Clinical Insights into the Enterovirus D68 Upsurge in Europe 2021–2022 and Emergence of Novel B3-Derived Lineages, ENPEN Multicentre Study
The Journal of Infectious Diseases 2024cited by 29position: middledoi
Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Frontiers in Immunology 2023cited by 36position: middledoi
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Blood 2022cited by 90position: middledoi
Outcome of infection with omicron <scp>SARS‐CoV</scp>‐2 variant in patients with hematological malignancies: An <scp>EPICOVIDEHA</scp> survey report
American Journal of Hematology 2022cited by 72position: middledoi
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
Haematologica 2022cited by 48position: middledoi
Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report
HemaSphere 2022cited by 34position: middledoi
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
Journal of Hematology & Oncology 2021cited by 316position: middledoi
COVID-19–Associated Pulmonary Aspergillosis, March–August 2020
Emerging infectious diseases 2021cited by 270position: middledoi
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
Blood 2021cited by 89position: middledoi
COVID-19 and CAR T cells: a report on current challenges and future directions from the EPICOVIDEHA survey by EHA-IDWP
Blood Advances 2021cited by 79position: middledoi
Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScopeⓇ—Global Registry for Emerging Fungal Infections
Journal of Infection 2020cited by 27position: middledoi
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)
Journal of Antimicrobial Chemotherapy 2019cited by 44position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 1 papers (2021–2021)Marina Machado · Texas Tech University1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2021–2021)Maricela Valerio · Universitat de Barcelona1 papers (2021–2021)Kennio Ferreira‐Paim · Universidade Federal do Triângulo Mineiro1 papers (2021–2021)Rosanne Sprute · TH Köln - University of Applied Sciences1 papers (2021–2021)Jon Salmanton‐García · University of Cologne1 papers (2021–2021)Philipp Koehler · RWTH Aachen University1 papers (2021–2021)Irma Hoyo · Universitat de Barcelona1 papers (2021–2021)Oliver A. Cornely · Agostino Gemelli University Polyclinic1 papers (2021–2021)Daniele Roberto Giacobbe · European Society of Clinical Microbiology and Infectious Diseases1 papers (2021–2021)Damien Dupont · Université Claude Bernard Lyon 11 papers (2021–2021)Carolina García‐Vidal · Hospital Clínic de Barcelona1 papers (2021–2021)Michele Bartoletti · Azienda USL di Bologna1 papers (2021–2021)Maria Schroeder · Universität Hamburg1 papers (2021–2021)Jacques F. Meis · Radboud University Nijmegen1 papers (2021–2021)Spinello Antinori · Ospedale dei Bambini Vittore Buzzi1 papers (2021–2021)Danila Seidel · Royal Brisbane and Women's Hospital1 papers (2021–2021)Frank Hanses · University Hospital Regensburg1 papers (2021–2021)